Benzinga | Nov 15, 2021 10:46AM EST

Piper Sandler Initiates Coverage On Ventyx Biosciences with Overweight Rating, Announces Price Target of $50

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Ventyx Biosciences (NASDAQ:VTYX) with a Overweight rating and announces Price Target of $50.